Spending

All articles by Spending

How DTC spending shifted in 2020
How DTC spending shifted in 2020
MM+M Staff
March 25, 2021
3:05 pm

Nielsen Ad Intel 2020 DTC data reveals changing trends in direct-to-consumer spending.

Pharma ad spend 2019: TV drug ad plateau
Pharma ad spend 2019: TV drug ad plateau
MM+M Staff
April 2, 2020
5:00 am

The data is in for 2019, and we break down the ad dollars being spent in different media and also look at the top brands.

7 things to know from Dartmouth’s medical marketing study
7 things to know from Dartmouth’s medical marketing study
Alison Kanski
January 14, 2019
10:34 am

Researchers found that spending on medical advertising reached nearly $30 billion in 2016, a $12 billion increase from 1997.

Five things for pharma marketers to know: Wednesday, March 14, 2018
Five things for pharma marketers to know: Wednesday, March 14, 2018
Lauren Evans
March 14, 2018
3:26 pm

Why the U.S. spends more on healthcare with worse results; Alnylam goes it alone on rare disease therapy; MorphoSys hopes for accelerated approval on MOR208.

Global adspend growth to accelerate to 4.7% in ‘stellar’ 2018
Global adspend growth to accelerate to 4.7% in ‘stellar’ 2018
Emily Tan
January 24, 2018
8:15 pm

Warc anticipates global adspend growth this year to ring in at a healthy 4.7%, or $572bn (£410bn).

Medical journal ad spend in H1 2017: All the data in one place
Medical journal ad spend in H1 2017: All the data in one place
Larry Dobrow
October 4, 2017
11:00 am

The top three most advertised brands were GlaxoSmithKline’s Breo Ellipta, Eli Lilly’s Trulicity, and Boehringer Ingelheim’s Jardiance.

Five things for pharma marketers to know: Thursday, June 1, 2017
Five things for pharma marketers to know: Thursday, June 1, 2017
Virginia Lau
June 1, 2017
2:30 pm

50% of consumers say they will share their health data with tech giants; pharma CEOs expect pricing proposal from Trump administration; FDA approves generic versions of Strattera

Pricing pressure is the new new normal for drugmakers
Pricing pressure is the new new normal for drugmakers
Kevin McCaffrey
May 30, 2017
11:00 am

Drug prices, as you may have heard, are kind of high. But price growth has slowed after sharp spikes in 2014 and 2015.

Nearly every $100,000 drug approved in the last three years was for a rare disease
Nearly every $100,000 drug approved in the last three years was for a rare disease
Kevin McCaffrey
May 24, 2017
12:51 pm

This includes Sarepta Therapeutics’ Exondys 5 and Vertex Pharmaceuticals’ Orkambi.

U.S. drug spend grew by 6% in 2016, the lowest rate in two years
U.S. drug spend grew by 6% in 2016, the lowest rate in two years
Kevin McCaffrey
May 4, 2017
4:10 am

This is likely due to fewer product launches and lower price increases.

  • From Our Partners